Vor Bio to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company focused on autoimmune disease treatments, has announced its participation in two upcoming investor conferences. The company will participate in a fireside chat at Citi's 2025 Biopharma Back to School Conference on September 2nd, 2025, at 11:15am ET in Boston. Additionally, Vor Bio will hold one-on-one investor meetings at the Baird 2025 Global Healthcare Conference on September 9th, 2025, in New York.

A live webcast of the Citi conference fireside chat will be accessible through the company's investor relations website at www.vorbio.com, where an archived replay will also be available.

News Market Reaction – VOR

+0.97%

7 alerts

+0.97% News Effect

+4.6% Peak Tracked

-8.1% Trough Tracked

+$3M Valuation Impact

$274.90M Market Cap

0.6x Rel. Volume

On the day this news was published, VOR gained 0.97%, reflecting a mild positive market reaction. Argus tracked a peak move of +4.6% during that session. Argus tracked a trough of -8.1% from its starting point during tracking. Our momentum scanner triggered 7 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $3M to the company's valuation, bringing the market cap to $274.90M at that time.

Data tracked by StockTitan Argus on the day of publication.

CAMBRIDGE, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it will participate in the following upcoming investor conferences:

Citi's 2025 Biopharma Back to School Conference
Fireside Chat: Tuesday, September 2nd, 2025, at 11:15am ET
Location: Boston, MA

A live webcast and archived replay of the fireside chat will be available on the investors section of www.vorbio.com.

Baird 2025 Global Healthcare Conference
1x1 Investor Meetings: Tuesday, September 9th, 2025
Location: New York, NY

About Vor Bio
Vor Bio is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. The Company is focused on rapidly advancing telitacicept, a novel dual-target fusion protein, through Phase 3 clinical development and commercialization to address serious autoantibody-driven conditions worldwide. For more information visit www.vorbio.com.

Media & Investor Contacts:
Carl Mauch
cmauch@vorbio.com

Sarah Spencer
investors@vorbio.com

FAQ

When is Vor Bio's fireside chat at Citi's 2025 Biopharma Conference?

Vor Bio's fireside chat is scheduled for Tuesday, September 2nd, 2025, at 11:15am ET in Boston, MA.

Where can investors watch Vor Bio's Citi conference presentation?

Investors can watch the live webcast and archived replay of the presentation on Vor Bio's investor relations website at www.vorbio.com.

What conferences will Vor Bio (VOR) attend in September 2025?

Vor Bio will attend Citi's 2025 Biopharma Back to School Conference on September 2nd and the Baird 2025 Global Healthcare Conference on September 9th.

What type of meetings will Vor Bio hold at the Baird 2025 Global Healthcare Conference?

Vor Bio will hold one-on-one investor meetings at the Baird 2025 Global Healthcare Conference in New York, NY on September 9th, 2025.